“The Nuclear β-Catenin Expression as a Prognostic Indicator and Its Clinicopathologic Correlates in Endometrial Adenocarcinoma: A Retrospective Study from Albayda Medical Center, Libya”, Razi Med J, pp. 363–368, Jun. 2026, doi: 10.69667/rmj.26229.